hydroxychloroquine has been researched along with Primary Immunodeficiency Diseases in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Primary Immunodeficiency Diseases: Genetic immunologic deficiency diseases and syndromes due to mutations in genes involved in IMMUNITY generally characterized by an increased susceptibility to infectious diseases. They are often associated with AUTOIMMUNE DISEASE manifestations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkan, G | 1 |
| Artac, H | 1 |
| Oz, SKT | 1 |
| Emiroglu, M | 1 |
| Li, GM | 1 |
| Liu, HM | 1 |
| Guan, WZ | 1 |
| Xu, H | 1 |
| Wu, BB | 1 |
| Feng, JY | 1 |
| Sun, L | 1 |
2 other studies available for hydroxychloroquine and Primary Immunodeficiency Diseases
| Article | Year |
|---|---|
Management of COVID-19 pneumonia in a child with NEMO deficiency.
Topics: Amides; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Serotherapy; Ectodermal Dysplasia; | 2021 |
A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus: A case report.
Topics: Adolescent; Antibodies, Antinuclear; Asian People; Class I Phosphatidylinositol 3-Kinases; Complemen | 2019 |